Diabetes is a disease resulting from a wrong lifestyle. High blood sugar does not cause coma and death. Low blood sugar is the culprit and is often caused by aggressive insulin shots. Gano-C is a better option in managing this disease since it naturally lowers blood sugar while boosting the immune system. Of course, the right lifestyle of eating and drinking is a crucial part.
Below are scientific research on ganoderma and diabetes for your reference:
- Effect of medicinal mushrooms on blood cells under conditions of diabetes mellitus.
- A novel PTP1B inhibitor extracted from Ganoderma lucidum ameliorates insulin resistance by regulating IRS1-GLUT4 cascades in the insulin signaling pathway.
- Polygonum cuspidatum inhibits pancreatic lipase activity and adipogenesis via attenuation of lipid accumulation.
- ReishiMax, mushroom based dietary supplement, inhibits adipocyte differentiation, stimulates glucose uptake and activates AMPK.
- Hypoglycemic mechanism of a novel proteoglycan, extracted from Ganoderma lucidum, in hepatocytes.
- Hypoglicemic and Hypolipedimic Effects of Ganoderma lucidum in Streptozotocin-Induced Diabetic Rats.
- Enzymatic System of Antioxidant Protection of Erythrocytes in Diabetic Rats Treated with Medicinal Mushrooms Agaricus brasiliensis and Ganoderma lucidum (Agaricomycetes).
- Novel hypoglycemic effects of Ganoderma lucidum water-extract in obese/diabetic (+db/+db) mice.
- Hypoglycemic effects of Ganoderma lucidum polysaccharides in type 2 diabetic mice.
- Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota.
- A novel proteoglycan from Ganoderma lucidum fruiting bodies protects kidney function and ameliorates diabetic nephropathy via its antioxidant activity in C57BL/6 db/db mice.
- Antidiabetic, antihyperlipidemic and antioxidant activities of a novel proteoglycan from ganoderma lucidum fruiting bodies on db/db mice and the possible mechanism.